Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Definition of the viral targets of protective HIV-1-specific T cell responses.
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
A therapeutic dendritic cell-based vaccine for HIV-1 infection.
Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection.
HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?
Dynamic escape of pre-existing raltegravir-resistant HIV-1 from raltegravir selection pressure.
Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.
Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.